JAMES R MCNAB
CIK 1190126 · last filed 2022-01-28
JAMES R MCNAB is a corporate insider who has filed 37 SEC Form 4 insider transactions across 2 companies since 2007. The most recent filing, for TTNP, was dated Jan 28, 2022. Across all open-market trades the lifetime net is −$3.0M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $411.0K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$411.0K
2
37
-$3.04M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| TITAN PHARMACEUTICALS INC (TTNP) Delisted | Director | 52,690 | $4.61 | $242.9K | $242.3K | 9 | 2022-01-28 |
| CRIS | Director | 975,964 | $0.42 | $411.0K | -$3.29M | 27 | 2017-05-05 |
Recent Filings
37 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2022-01-28 | TITAN PHARMACEUTICALS INC (TTNP) Delisted | Other (J) | +51,021 | $0 | EDGAR |
| 2022-01-05 | TITAN PHARMACEUTICALS INC (TTNP) Delisted | Grant (A) | — | $0 | EDGAR |
| 2021-02-11 | TITAN PHARMACEUTICALS INC (TTNP) Delisted | Grant (A) | — | $0 | EDGAR |
| 2018-09-25 | TITAN PHARMACEUTICALS INC (TTNP) Delisted | Mixed | +200,000 | $50.0K | EDGAR |
| 2017-09-19 | TITAN PHARMACEUTICALS INC (TTNP) Delisted | Grant (A) | — | $0 | EDGAR |
| 2017-05-05 | CRIS | Sell (S) | −76,276 | -$155.4K | EDGAR |
| 2017-05-05 | CRIS | Sell (S) | −76,276 | -$155.4K | EDGAR |
| 2017-05-02 | CRIS | Sell (S) | −116,708 | -$278.0K | EDGAR |
| 2017-04-27 | CRIS | Sell (S) | −146,694 | -$383.0K | EDGAR |
| 2017-04-27 | CRIS | Sell (S) | −110,322 | -$285.7K | EDGAR |